Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young N Park

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 27, 2021
Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosisJongjin Yoon, Jeong A Hwang, Sunyoung Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levelsJae Y Cheong, Dong J Kim, Seong G Hwang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659Ji-Hye Choi, So M Kwon, Sung U Moon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 9, 2013
Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapyBeom K Kim, Hyun J Oh, Jun Y Park, et al.
Scientific Reports|July 5, 2019
CRISPR knockout screen implicates three genes in lysosome functionGuy M Lenk, Young N Park, Rosemary Lemons, et al.
Histopathology|March 25, 2018
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Alastair D Burt, Venâncio Alves, Pierre Bedossa, et al.
HGG Advances|July 3, 2024
A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variantsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Predictive modeling provides insight into the clinical heterogeneity associated with <i>TARS1</i> loss-of-function mutationsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinomaGi H Choi, Jun Y Park, Ho K Hwang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 9, 2024
Biallelic loss-of-function variants of SLC12A9 cause lysosome dysfunction and a syndromic neurodevelopmental disorderAndrea Accogli, Young N Park, Guy M Lenk, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Liver International : Official Journal of the International Association for the Study of the Liver|January 27, 2021
Clinicopathologic and MRI features of combined hepatocellular-cholangiocarcinoma in patients with or without cirrhosisJongjin Yoon, Jeong A Hwang, Sunyoung Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levelsJae Y Cheong, Dong J Kim, Seong G Hwang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659Ji-Hye Choi, So M Kwon, Sung U Moon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 9, 2013
Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapyBeom K Kim, Hyun J Oh, Jun Y Park, et al.
Scientific Reports|July 5, 2019
CRISPR knockout screen implicates three genes in lysosome functionGuy M Lenk, Young N Park, Rosemary Lemons, et al.
Histopathology|March 25, 2018
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Alastair D Burt, Venâncio Alves, Pierre Bedossa, et al.
HGG Advances|July 3, 2024
A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variantsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Predictive modeling provides insight into the clinical heterogeneity associated with <i>TARS1</i> loss-of-function mutationsRebecca Meyer-Schuman, Allison R Cale, Jennifer A Pierluissi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinomaGi H Choi, Jun Y Park, Ho K Hwang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 9, 2024
Biallelic loss-of-function variants of SLC12A9 cause lysosome dysfunction and a syndromic neurodevelopmental disorderAndrea Accogli, Young N Park, Guy M Lenk, et al.
Pageof 2